Shiao-Lin Tung

1.2k total citations
20 papers, 477 citations indexed

About

Shiao-Lin Tung is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shiao-Lin Tung has authored 20 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shiao-Lin Tung's work include Hematopoietic Stem Cell Transplantation (3 papers), Acute Myeloid Leukemia Research (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Shiao-Lin Tung is often cited by papers focused on Hematopoietic Stem Cell Transplantation (3 papers), Acute Myeloid Leukemia Research (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Shiao-Lin Tung collaborates with scholars based in Taiwan and United States. Shiao-Lin Tung's co-authors include Wei-Chieh Huang, Lu‐Hai Wang, Te‐Hsuan Jang, Po‐Ming Chen, Tzu‐Chen Yen, Pei‐Yi Chu, Shih‐Hsuan Chan, Sheng‐Chieh Lin, Shuang‐En Chuang and Yayu Yang and has published in prestigious journals such as Oncogene, The American Journal of Gastroenterology and Human Pathology.

In The Last Decade

Shiao-Lin Tung

20 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiao-Lin Tung Taiwan 10 265 179 142 81 66 20 477
Yanjun Gu China 11 348 1.3× 208 1.2× 166 1.2× 77 1.0× 52 0.8× 24 532
Wei-Chieh Huang Taiwan 12 393 1.5× 239 1.3× 135 1.0× 67 0.8× 61 0.9× 22 578
Yanjie You China 15 307 1.2× 144 0.8× 196 1.4× 65 0.8× 80 1.2× 46 527
Suchitra Natarajan United States 8 226 0.9× 126 0.7× 130 0.9× 48 0.6× 42 0.6× 13 379
Maria A. Voronkova United States 9 280 1.1× 114 0.6× 119 0.8× 91 1.1× 56 0.8× 15 452
Natascha Cremers Germany 11 239 0.9× 137 0.8× 290 2.0× 92 1.1× 63 1.0× 12 516
Simon Lavotshkin United States 5 355 1.3× 236 1.3× 227 1.6× 110 1.4× 64 1.0× 8 589
Wen Min Lau United States 9 290 1.1× 93 0.5× 173 1.2× 62 0.8× 55 0.8× 10 423
Shunlin Jiang United States 10 349 1.3× 137 0.8× 104 0.7× 59 0.7× 41 0.6× 14 499

Countries citing papers authored by Shiao-Lin Tung

Since Specialization
Citations

This map shows the geographic impact of Shiao-Lin Tung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiao-Lin Tung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiao-Lin Tung more than expected).

Fields of papers citing papers by Shiao-Lin Tung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiao-Lin Tung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiao-Lin Tung. The network helps show where Shiao-Lin Tung may publish in the future.

Co-authorship network of co-authors of Shiao-Lin Tung

This figure shows the co-authorship network connecting the top 25 collaborators of Shiao-Lin Tung. A scholar is included among the top collaborators of Shiao-Lin Tung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiao-Lin Tung. Shiao-Lin Tung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jang, Te‐Hsuan, Wei-Chieh Huang, Shiao-Lin Tung, et al.. (2022). MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway. Journal of Biomedical Science. 29(1). 42–42. 69 indexed citations
2.
Chu, Pei‐Yi, Wei-Chieh Huang, Shiao-Lin Tung, et al.. (2022). IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis. Cell & Bioscience. 12(1). 124–124. 22 indexed citations
3.
Lin, Sheng‐Chieh, Yi-Chu Liao, Po‐Ming Chen, et al.. (2022). Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-κB and TGF-β2 signaling. Journal of Biomedical Science. 29(1). 109–109. 76 indexed citations
4.
Huang, Wei-Chieh, Shiao-Lin Tung, Po‐Ming Chen, et al.. (2022). Novel function of THEMIS2 in the enhancement of cancer stemness and chemoresistance by releasing PTP1B from MET. Oncogene. 41(7). 997–1010. 12 indexed citations
5.
6.
Chu, Pei‐Yi, et al.. (2020). Identification of the Novel Oncogenic Role of SAAL1 and Its Therapeutic Potential in Hepatocellular Carcinoma. Cancers. 12(7). 1843–1843. 9 indexed citations
7.
Huang, Wei-Chieh, Te‐Hsuan Jang, Shiao-Lin Tung, et al.. (2019). A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 89–89. 80 indexed citations
8.
Huang, Wei-Chieh, Shiao-Lin Tung, Yao‐Li Chen, Po‐Ming Chen, & Pei‐Yi Chu. (2018). IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway. BMC Cancer. 18(1). 609–609. 46 indexed citations
9.
Chen, Po‐Ming, Pei‐Yi Chu, Shiao-Lin Tung, et al.. (2017). Overexpression of phosphoprotein phosphatase 2A predicts worse prognosis in patients with breast cancer: a 15-year follow-up. Human Pathology. 66. 93–100. 8 indexed citations
10.
11.
Yang, Muh‐Hwa, Liming Bai, L. T. Hsiao, et al.. (2005). Relatively favorable outcomes of post‐transplant pulmonary function in patients with chronic myeloid leukemia receiving non‐myeloablative allogeneic hematopoietic stem cell transplantation. European Journal Of Haematology. 74(2). 152–157. 2 indexed citations
12.
Chiou, Tzeon-Jye, Shiao-Lin Tung, Wei-Shu Wang, et al.. (2002). Pulmonary Function Changes in Long-Term Survivors of Chronic Myelogenous Leukemia After Allogeneic Bone Marrow Transplantation: A Taiwan Experience. Cancer Investigation. 20(7-8). 880–888. 13 indexed citations
13.
Tung, Shiao-Lin. (2000). Risk factors for colorectal adenomas among immediate family members of patients with colorectal cancer in Taiwan: a case-control study. The American Journal of Gastroenterology. 95(12). 3624–3628. 1 indexed citations
14.
Chiou, Tzeon Jye, et al.. (1999). ESHAP as Salvage Therapy for Refractory Non-Hodgkin's Lymphoma: Taiwan Experience. Japanese Journal of Clinical Oncology. 29(1). 33–37. 19 indexed citations
15.
Yen, Chueh‐Chuan, Ruey‐Kuen Hsieh, Tzeon Jye Chiou, et al.. (1998). Navoban (Tropisetron, ICS 205-930) and Dexamethasone Combination in the Prevention of Vomiting for Patients Receiving Preconditioning High-dose Chemotherapy Before Marrow Transplantation. Japanese Journal of Clinical Oncology. 28(2). 129–133. 4 indexed citations
16.
Hsieh, Ruey‐Kuen, Tzeon Jye Chiou, Liu H, et al.. (1998). Toxic Cardiogenic Shock in a Patient Receiving Weekly 24-h Infusion of High-dose 5-Fluorouracil and Leucovorin. Japanese Journal of Clinical Oncology. 28(9). 551–554. 5 indexed citations
17.
Chiou, Tzeon Jye, Shiao-Lin Tung, Ruey‐Kuen Hsieh, et al.. (1998). Phase II Study of the Modified Regimen of Etoposide, Leucovorin and 5-Fluorouracil for Patients with Advanced Gastric Cancer. Japanese Journal of Clinical Oncology. 28(5). 318–322. 3 indexed citations
18.
Tung, Shiao-Lin, et al.. (1997). Unusual electroencephalographic findings in subacute sclerosing panencephalitis: a case report. Brain and Development. 19(3). 222–225. 9 indexed citations
19.
20.
Chiou, Tzeon Jye, et al.. (1996). Bone marrow transplantation with HLA partially matched related donors.. PubMed. 58(6). 385–91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanjun Gu Breakdown of academic impact, for papers by Wei-Chieh Huang Breakdown of academic impact, for papers by Yanjie You Breakdown of academic impact, for papers by Suchitra Natarajan Breakdown of academic impact, for papers by Maria A. Voronkova Breakdown of academic impact, for papers by Natascha Cremers Breakdown of academic impact, for papers by Simon Lavotshkin Breakdown of academic impact, for papers by Wen Min Lau Breakdown of academic impact, for papers by Shunlin Jiang
Rankless by CCL
2026